Notice ID: 1942c212a14843a1bedafe79ec8d6ddaSpecial Notice
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
Active, responses due . Full description on SAM.gov.
Overview
- Response deadline
- 11:59 PM EDT
- Posted
- June 12, 2024
- Notice type
- Special Notice
- NAICS
- 541720: Research and Development in the Social Sciences and Humanities
- Agency
- Department of WarDEFENSE HEALTH AGENCY (DHA)
Notice details
- Office
- ARMY MED RES ACQ ACTIVITY
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- HT9425-23-S-SOC1
- Notice ID
- 1942c212a14843a1bedafe79ec8d6dda
Description
This BAA is intended to solicit extramural research and development ideas using the authority provided by United States Code, Title 10, Section 4001. This BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in Federal Acquisition Regulation 6.102(d) (2) and 35.016. In accordance with FAR 6.102, projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution. Research and development funding through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge. This BAA provides a general description of USSOCOM's research and development programs, including research areas of interest, evaluation and selection criteria, pre-proposal/pre-application and full proposal/application preparation instructions, and general administrative information. Submission of a pre-proposal is required. After review, if the USSOCOM is interested in receiving a full proposal, the Offeror will be invited to submit a full proposal or full application. Specific submission information and additional administrative requirements can be found in the document titled "General Submission Instructions" available in Grants.gov along with this BAA The BAA is continuously open for a 5-year period, from 01 August 2023 through 31 July 2028, at 11:59 p.m. Eastern Time. Submission of a pre-proposal is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org/). Preproposals may be submitted at any time throughout the 5-year period. If the USSOCOM is interested in receiving a full proposal/application, the Principal Investigator will be sent an invitation to submit via eBRAP. A full proposal/application must be submitted through Grants.gov (http://www.grants.gov/). Invited full proposals/applications can be submitted under this BAA through 31 July 2028. The BAA with revised research areas of interests, and General Submission Instructions will be available for download on Grants.gov upon revisions. Search opportunity number HT9425-23-S-SOC1.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Files (3)
Links (1)
- Grants.gov package linkwww.grants.govPosted
Lifecycle
- 1Version 1Special Notice
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical Research and Development - HT9425-23-S-SOC1
- 2Version 2Special Notice
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
- 3Version 3Special NoticeCurrent
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
This BAA is intended to solicit extramural research and development ideas using the authority provided by United States Code, Title 10, Section 4001. This BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in Federal Acquisition Regulation 6.102(d) (2) and 35.016. In accordance with FAR 6.102, projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution. Research and development funding through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge. This BAA provides a general description of USSOCOM's research and development programs, including research areas of interest, evaluation and selection criteria, pre-proposal/pre-application and full proposal/application preparation instructions, and general administrative information. Submission of a pre-proposal is required. After review, if the USSOCOM is interested in receiving a full proposal, the Offeror will be invited to submit a full proposal or full application. Specific submission information and additional administrative requirements can be found in the document titled "General Submission Instructions" available in Grants.gov along with this BAA The BAA is continuously open for a 5-year period, from 01 August 2023 through 31 July 2028, at 11:59 p.m. Eastern Time. Submission of a pre-proposal is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org/). Preproposals may be submitted at any time throughout the 5-year period. If the USSOCOM is interested in receiving a full proposal/application, the Principal Investigator will be sent an invitation to submit via eBRAP. A full proposal/application must be submitted through Grants.gov (http://www.grants.gov/). Invited full proposals/applications can be submitted under this BAA through 31 July 2028. The BAA with revised research areas of interests, and General Submission Instructions is available for download on Grants.gov. Search opportunity number HT9425-23-S-SOC1. | - | Special Notice | 07/31/2028 |
This RPP is being issued by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency’s Portfolio Acquisition Executive (PAE) Medical Products (MP) Warfighter Protection (WPAC) & Acute Care Program Management Office (PMO) Care located in Frederick, Maryland at Fort Detrick. The Warfighter Protection and Acute Care Project Management Office (WPAC PMO) has a requirement for the development of a Barrier Combination product. The Barrier Combination product is defined as being composed of both a physical barrier to protect a wound and an antibacterial and/or antifungal activity released from the barrier to prevent the spread of organisms and avoid systemic infections. This RPP will result in one award to develop the Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination (BC) prototype product. The final product MUST be a combination wound treatment that includes a barrier component that is either infused or impregnated with antimicrobial and/or antifungal properties and have U.S. Food Drug Administration (FDA) approval (or clearance). The award, as a result of this RPP, will be awarded under the authority of prototype Other Transaction Authority (pOTA) 10 U.S.C. 4022. NOTE: Another amendment will be posted which will include Offeror questions and Government responses. (Amendment 0003 only extends the proposal due date). Amendment 0001 – removed alternate point of contact information under “Contract Information” on SAM.gov Amendment 0002 – revised proposal due date from: 12:00pm eastern, Friday, 23 Oct 2026 to: 12:00pm eastern Friday, 06 Nov 2026 Amendment 0003 – revised proposal due date from: 12:00pm eastern Friday, 06 Nov 2026 to: 12:00pm eastern Friday, 20 Nov 2026 | - | Solicitation | 11/20/2026 |
The Defense Health Agency Contracting Activity, on behalf of Portfolio Acquisition Executive for Medical Products, Warfighter Protection and Acute Care Project Management Office, intends to issue a contract modification on a sole-source basis with Westat Inc. 1600 Research Blvd. Rockville, MD 20850. This modification will enable Westat Inc. to modify the current clinical trial design to comply with FDA recommendations and to conduct the Good Clinical Practices (GCP) compliant clinical trial in accordance with U.S. Food and Drug Administration’s requirements for EZPLAZ™ approval. | - | Market Research | 11/16/2026 |
Amendment 0001 to this notice is to push out the anticipated posting of the solicitation to late November 2026. This is a pre-solicitation notice to synopsize the intention of the Defense Health Agency Contracting Activity (DHACA) to issue a Request for Proposal (RFP) for an on-ramp to the OMNIBUS IV Multiple Award, Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle covering military medical research and development services. A historical pre-solicitation notice was posted under Notice ID# HT942626RE002, although there were various delays with getting a solicitation out in Fiscal Year 2026. This notice is taking over where Notice ID# HT942626RE002 left off. No further delays are anticipated at this time for this on-ramp. The eventual RFP will be set-aside for small businesses certified under the Small Business Administration 8(a) Program. The Government anticipates making multiple new awards under this on-ramp, and all new awards will align with the existing unrestricted contract vehicle. This notice is not a request for proposals and does not commit the Government to any contractual agreement. The OMNIBUS IV contract vehicle was awarded under full and open competition with a base ordering period of 20 June 2022 through 19 June 2027 and an Option Ordering Period of 20 June 2027 - 19 June 2032. Task orders may be competed under fair opportunity (providing all Contract Holders within a Market Segment the opportunity to submit a proposal) or an exception to fair opportunity (such as set-asides for small businesses or applicable small business socioeconomic categories). The cumulative ceiling of this unrestricted IDIQ contract vehicle is $10 billion. To date, the accumulated awarded task order value (including future unexercised option periods) is over $690 million across 61 task orders. Task Orders have been issued by a growing number of end users including DHACA, the U.S. Army Medical Research Acquisition Activity (now integrated into DHACA), the Naval Supply Systems Command, and the Uniformed Services University of the Health Sciences. When excluding the task orders simply providing a minimum guarantee to the existing Contract Holders, 61 task orders have been issued off this contract vehicle with 8 task orders being set aside for the 8(a) Program and 15 task orders being awarded to an 8(a) Participant (based on the most recent representations at the contract level). 42 task orders have been awarded so far to small businesses under this contract vehicle. Of the 61 task orders, 95% were awarded during the Government Fiscal Years 2024 - 2026. Please see attachments for further details. | - | Pre-Solicitation | Open |
The Defense Health Agency Contracting Activity (DHACA) intends to issue a sole source award. The Defense Health Agency, Science and Technology Portfolio Management Division (STPMD) will co-sponsor a Forum on Traumatic Brain Injury (TBI) hosted by the National Academy of Science, Engineering, and Medicine (NASEM). The forum will provide STPMD on ongoing mechanism and neutral setting in which the full spectrum of Government stakeholders and public and private sector Subject Matter Experts (SMEs) to explore opportunities for collective action directed towards advancement in TBI care and research. The requirement contains a base year plus 4 option years. The NASEM will convene the Forum on TBI two (2) to three (3) times per year to provide and ongoing mechanism and neutral setting in which the full spectrum of Government stakeholders and public and private sector SMEs will share information and explore opportunities for collective action addressing contemporary topics in TBI and research. Forum members will address short- and long-term strategic planning for advancing TBI care and research spanning the full TBI continuum from prevention through acute care and rehabilitation. NASEM has established these forums as part of contract W81XWH22C0033. DHA is planning to participate as a key stakeholder. STPMD requires access to these Forums along with other military services and federal agencies. Any firm that believes it can provide the stated capability as outlined above are invited to submit a written notification to the Contracting Office NLT 2PM ET on 18 November 2026. Supporting evidence must be furnished in sufficient detail to demonstrate the firm’s ability to provide the stated capability. Information shall be sent electronically (via e-mail only) to Rich Trunnell, Contract Specialist, at richard.k.trunnell.civ@health.mil. No telephone requests will be accepted. Responses received will be evaluated; however; a determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. If no responses are received, DHACA will proceed with the sole sources contract. | - | Special Notice | 11/18/2026 |
Additional Details
Solicitation Number
HT9425-23-S-SOC1
Archive Date
Aug 15, 2028
Office Address
FORT DETRICK, MD, 21702